Veterinary Biologics Market to Reach $3.69 Billion by 2031: Insights and Growth Factors

Veterinary Biologics Market Overview


The veterinary biologics market is poised for significant growth, projecting a total worth of approximately $3.69 billion by the year 2031. This increase is substantial from the estimated market size of $2.85 billion in 2026, representing a compound annual growth rate (CAGR) of about 5.3% during the forecast period.

Market Insights


Recent analysis indicates that North America is set to lead this market, with a potential to witness the highest growth rate between 2026 and 2031. Breakdown by product reveals that monoclonal antibodies dominate the market, accounting for 58.2% in 2025.

The surge in the veterinary biologics market aligns with the rise in chronic pet diseases such as atopic dermatitis and osteoarthritis. As these health concerns grow, there’s an escalating demand for effective treatment solutions. The emphasis on pets' health and well-being is further pushing the demand for enhanced veterinary care globally.

Key Trends Identified


  • - Monoclonal Antibodies Growth: The segment related to monoclonal antibodies is expected to accelerate swiftly due to their targeted action and high efficacy, especially in livestock health management.
  • - Dermatology Application Growth: The dermatology application segment is anticipated to experience the highest CAGR of 5.7% in the analysis period, attributed to the growing incidence of skin disorders arising from allergies and infections among pets.
  • - Veterinary Clinics and Hospitals Expansions: An increase in veterinary clinics and hospitals enhances the overall scope for the veterinary biologics market, as more resources are directed towards animal healthcare.

Regional Dynamics


North America is leading the charge in market share due to a booming pet population, heightened awareness of animal welfare, and increased budgets for veterinary care. Regions like China, India, and Japan are also witnessing notable growth fueled by advanced veterinary services and industries relying heavily on livestock farming.

Investment and Innovation


Investment within the veterinary biologics sector has been on the rise, yet fluctuated in recent years, dropping from $740 million in 2021 to $530 million in 2022. However, signs of recovery are already visible with $610 million in 2023 and projections estimating approximately $780 million in 2025. Funding trends indicate continued interest in veterinary biotechnology and monoclonal drug development, which could pave the way for new products and therapeutic advances in the coming years.

Mergers and Acquisitions


Recent industry activities reflect a burgeoning environment for mergers and acquisitions. Notably:
  • - In February 2026, Covetrus and MWI Animal Health finalized a merger to strengthen their animal-health distribution networks.
  • - In November 2025, Zoetis Inc. expanded its market footprint by acquiring the UK-based Veterinary Pathology Group.
  • - In September 2024, Boehringer Ingelheim added to its research capabilities by acquiring Saiba Animal Health in Switzerland.

Key Players in the Market


Significant players shaping the future of the veterinary biologics market include:
  • - Zoetis Services LLC (US)
  • - IDEXX (US)
  • - Elanco (US)
  • - Merck & Co., Inc. (US)
  • - Boehringer Ingelheim International GmbH (Germany)
  • - Thermo Fisher Scientific Inc. (US)

These companies leverage their extensive distribution networks, development capabilities, and regulatory expertise to maintain competitive advantages in the industry.

Conclusion


The veterinary biologics market stands at a pivotal point driven by emerging trends in animal health, product innovation, and a global shift toward more effective treatment methods. As consumer awareness grows alongside pet ownership rates, the push for high-quality veterinary care and biologics continues to gather momentum, ensuring this market remains a critical area for investment and development in the foreseeable future.

Topics Health)

【About Using Articles】

You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.

【About Links】

Links are free to use.